1. Home
  2. VRCA vs LITB Comparison

VRCA vs LITB Comparison

Compare VRCA & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRCA
  • LITB
  • Stock Information
  • Founded
  • VRCA 2013
  • LITB 2007
  • Country
  • VRCA United States
  • LITB Singapore
  • Employees
  • VRCA N/A
  • LITB N/A
  • Industry
  • VRCA Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • VRCA Health Care
  • LITB Consumer Discretionary
  • Exchange
  • VRCA Nasdaq
  • LITB Nasdaq
  • Market Cap
  • VRCA 32.7M
  • LITB 36.4M
  • IPO Year
  • VRCA 2018
  • LITB N/A
  • Fundamental
  • Price
  • VRCA $3.77
  • LITB $2.92
  • Analyst Decision
  • VRCA Hold
  • LITB
  • Analyst Count
  • VRCA 2
  • LITB 0
  • Target Price
  • VRCA N/A
  • LITB N/A
  • AVG Volume (30 Days)
  • VRCA 247.5K
  • LITB 32.2K
  • Earning Date
  • VRCA 11-06-2025
  • LITB 12-09-2025
  • Dividend Yield
  • VRCA N/A
  • LITB N/A
  • EPS Growth
  • VRCA N/A
  • LITB N/A
  • EPS
  • VRCA N/A
  • LITB 0.12
  • Revenue
  • VRCA $14,704,000.00
  • LITB $220,656,000.00
  • Revenue This Year
  • VRCA $332.45
  • LITB N/A
  • Revenue Next Year
  • VRCA $12.85
  • LITB N/A
  • P/E Ratio
  • VRCA N/A
  • LITB $24.61
  • Revenue Growth
  • VRCA 5.72
  • LITB N/A
  • 52 Week Low
  • VRCA $3.28
  • LITB $0.91
  • 52 Week High
  • VRCA $13.60
  • LITB $4.17
  • Technical
  • Relative Strength Index (RSI)
  • VRCA 44.18
  • LITB 53.07
  • Support Level
  • VRCA $3.37
  • LITB $2.79
  • Resistance Level
  • VRCA $3.99
  • LITB $3.26
  • Average True Range (ATR)
  • VRCA 0.25
  • LITB 0.44
  • MACD
  • VRCA 0.03
  • LITB -0.08
  • Stochastic Oscillator
  • VRCA 45.12
  • LITB 23.93

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: